Treat the health of your entire healthcare system. DLA Piper's lawyers provide guidance to help you tend to your system's wellness throughout the business life cycle.
CMS and OIG release most expansive changes to the fraud and abuse laws in over a decade: Organizations seeking to resolve criminal charges brought by the DOJ now have a clearly defined framework for an ability-to-pay argument.
Amendment to Florida Patient Brokering Act may impact previously protected arrangements: The bill's application extends well beyond the substance abuse space to essentially all Florida healthcare providers.
Healthcare market proves strong with investors finding returns generally outweigh the risk: Understanding industry trends and managing risk assessment.
Fifth Circuit Court of Appeals affirms CMS demand for return of $8 million from failed care management demonstration project: In a demonstration project, the provider's rights and remedies must be expressed in the grant agreement.
The cybersecurity of digital medical devices: Higher technological capabilities, higher likelihood of liability – prudent medical device manufacturers are assessing their compliance with HIPAA and FDA Draft Guidance, then completing a Risk Management Plan.
Explainability: where AI and liability meet: Makers and users of AI face a new and interesting problem – what is the acceptable tradeoff between explanation and accuracy?
Plaintiff attorney advertising in pharmaceutical and medical device litigation: Regulatory bodies are recognizing that such advertising has the potential to cause harm and that some guardrails are necessary.
The learned intermediary doctrine in the WebMD era: The US medical system continues to put the physician between the treatment and the patient for a reason.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
